Effect of oral mizoribine pulse therapy for frequently relapsing steroid-dependent nephrotic syndrome

Clinical Nephrology

Volumn 69, Issue 3, 2008, Pages 179-184

  Fujieda, M ^a   Ishihara, M ^a   Morita, T ^a   Hayashi, A ^b   Utsunomiya, Y ^c   Ohta, T ^d   Sakano, T ^d   Wakiguchi, H ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c Tottori Prefectural Kosei Hospital   (Japan)

^d HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

Author keywords

Frequently relapsing nephrotic syndrome; Mizoribine; Steroid dependency

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MIZORIBINE; PREDNISOLONE; STEROID;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MALE; MAXIMUM PERMISSIBLE DOSE; MORNING DOSAGE; NEPHROTIC SYNDROME; PHASE 2 CLINICAL TRIAL; RELAPSE;

EID: 40449140722     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP69179     Document Type: Article

References (12)